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ABSTRACT
Objective: Amygdalus eburnea is a perennial herb that has been valued for its important biological perspectives and it has been used to treat the burn. 
This study aims to evaluate wound healing activity of A. eburnea extract compared with silver sulfadiazine (a synthetic burn ointment) for treating 
the induced third-degree burn in rat.
Methods: In this study, a deep, third-degree burn wound was induced by a hot plate warmed 5 minutes within boiling water and placed for 3 seconds 
on the skin. The shell root of A. eburnea an Iranian medicinal herb is investigated on its wound healing activity in comparison with silver sulfadiazine 
ointment as the standard treatment for burn wound in rats.
Results: Our results demonstrated that A. eburnea can be an effective treatment for third-degree burns. Advanced clinical and pharmaceutical studies 
are recommended to the production of novel natural drugs for burn wound treatment.
Conclusion: A. eburnea can be an effective treatment for third-degree burns. Advanced clinical and pharmaceutical studies are recommended to the 
production of novel natural drugs for burn wound treatment.
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INTRODUCTION
Burn injury is a global public health issue especially for the 
developing [1] and undeveloped countries, which suffer from lack of 
adequate medical facilities. Burns are one of the most common forms 
of injury with devastating concerns [2]. Burn is tissue injury caused by 
heat, electricity, chemicals, radiation, etc. According to the depth, burn 
wounds are categorized as first degree (superficial), second degree 
(partial thickness), and third degree (full thickness) [3]. Dressing is 
required to protect against the environmental flora and evaporative 
heat loss and accentuate the healing period because thermal injury 
disrupts the protective barrier function of skin. The ultimate burn 
dressing wound is cheap and comfortable; it cause the burn to heal 
rapidly and it cleans the wound and devitalized tissue and debride 
fragments of separated eschar and have an antibacterial activity [4,5]. 
Wound healing is a complex process including many physiological 
actions and responses, requiring the collaborative effects of different 
cells and tissues [6]. Severe burn wounds must be treated rapidly since 
any delay may cause infection or postpone the healing process [3]. Most 
of the early treatments include topical application of medicaments are 
necessary to prevent infections [7]. In severe burns, septicemia and 
infection are the main factors of mortality among these patients [8]. 
Burn wound healing is still a challenge to modern medicine despite the 
discovery of several antiseptics [2]. Although many improvements have 
been made to treat burn injuries, the best treatment to hasten healing 
has not been reached yet [9].
Many of the synthetic drugs cause problems such as drug resistance and 
allergy. Hence, many scientists are trying to seek alternative drugs [10]. 
More than 80% of the world’s population utilizes traditional medicines 
for various skin diseases [11]. Recently, the traditional usage of plants 
has received considerable attention for wound healing by the scientific 
community [11,12]. Approximately, one-third of all using traditional 
medicines are for the treatment of wounds and skin disorders, 
compared to only 1-3% of modern drugs [13,14]. Herbal products 
have moderate efficacy with no or less toxicity and are cheaper than 
synthetic drugs [15]. Medicinal plants can act as wound healing agents 
because of their vast variety of different constituents such as alkaloids, 
tannins, terpenoids, essential oils, saponins, flavonoids, fatty acids, and 
phenolic compounds [16], which have the capability to improve healing 
process of burn wound. Low cost, availability and fewer side effects 
such as allergy and drug resistance are other advantages of herbal 
remedies [3,17,18].
Amygdalus eburnea Spach. is a plant from Rosaceae family and it is a 
type of almond which is naturally grown and distributed in Iran. This 
plant is called “Ghosk” in Persian, which has been used in semi-desert 
areas to control soil erosion and stabilized watersheds [19]. Moreover, 
it has been used as wound healing of burn since ancient time by people 
of southeast of Iran. In traditional Iranian medicine, A. eburnea has also 
been utilized successfully as laxative and anti-worm. Furthermore, brew 
of dermal tissue is used for cough, respiratory distress, and paregoric. 
Moreover, in modern medicine, various pharmacological properties 
such as antioxidant, antifungal, antibacterial, and antidermatophyte 
have been related to this plant [20-24]. This study aims to evaluate 
wound healing activity of A. eburnea extract compared with silver 
sulfadiazine (a synthetic burn ointment) for treating the induced third-
degree burn in rat.
METHODS
Collection of plant materials
The shell root of A. eburnea was collected from rural regions of from 
Baft district, the Southeast of Iran, in April 2013. They were identified 
by a botanist of the Botany Department of Shahid Bahonar University, 
Kerman, Iran. A voucher specimen of the plant materials was deposited 
at the Herbarium of Department of Pharmacognosy, School of Pharmacy, 
Kerman University of Medical Science, Iran (KF 1136).
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Preparing of extracts
About 100 g of powdered plant material was separately extracted by 
percolation method with methanol (80%) and water successively for 
72 hrs in room temperature. The extracts were passed through filter 
paper (Whatman No. 3, Sigma, Germany) to remove plant debris. 
The extracts were finally concentrated in vacuum at 50°C using a 




This study was conducted in strict accordance with the recommendations 
in the guide for the Care and Use of Laboratory Animals of the National 
Institutes of Health. The protocol was approved by the Committee on 
the Ethics of Animal Experiments of the Kerman University of Medical 
Science (Permit Number: 1508). Moreover, all efforts were made to 
minimize suffering.
Animals
Mal Wistar rats weighing from 200 to 250 g were obtained from the 
Animal Breeding Stock Facility of Razi Institute of Iran (Karaj, Iran). 
Animals were housed in a colony room with a 12:12 hrs light/dark cycle 
at 21±2°C and were handled according to standard protocols for the use 
of laboratory animals. During the tests, the temperature of the room 
and humidity were controlled. For the experiments, the animals were 
selected randomly into three groups: Topical A. eburnea treated group, 
topical silver sulfadiazine treated group, and untreated or control 
group.
Establishment of third-degree burn wound
A deep, third-degree burn wound was induced by a hot plate warmed 
5 minutes within boiling water and placed for 3 seconds on the skin. 
Immediately after burn, animals received an intraperitoneal injection 
of 1 ml normal saline to prevent shock caused by burns. Burns were 
dressed daily with A. eburnea extract in Group 1 and silver sulfadiazine 
in Group 2. Responses to the treatment were assessed by digital 
photography during the treatment until day 15.
Wound analysis
The wound closure rate was assessed by tracing the wound on day 3, 6, 
12 and 15 then percentage of recovery of all groups was compared. Time 
to wound closure was defined when the wound bed was completely 
re-epithelialized and filled with new tissue. The wound healing rate was 
calculated with a formula as following:
Percent of wound=Area of remaining wound/Area of original 
wound×100 (1)
Percent of recovery=100−Percent of wound.
Pathological study
Pathology examination was carried out on the skin biopsies on the 6 
and 12 days after injury. Skin biopsies were examined after blocking 
and preparing cuts of 3 µm by microtome (Leitz 1512) and stained with 
hematoxylin-eosin.
RESULTS AND DISCUSSION
Wound healing rates were measured at day 3, 6, 12, and 15 after the 
wounding. The effect of the extract on wound healing activity in rats 
compared with the control rats and silver sulfadiazine treated group 
values of p<0.05 were considered as statistically significant. The 
average percent of wound healing rates on the 3rd day for extract, silver 
and control group was 9.51%, 7.17% and 7.88%, respectively. The 
overall average wound healing rates on the 3rd day were 8.19% that the 
highest (25.66%) and lowest (−1.48%) wound healing rates on the 3rd 
day were belonging to extract and silver group, respectively. However, 
the silver group shows highest and lowest 47.54% and 4.07% wound 
healing rates on the 6th day. Nevertheless, in the 12th and 15th day, the 
procedure was same that the maximum wound healing rates that are 
belong to extract group were 79.74% and 90.32%, respectively. In all 
groups, wound healing rates increased with time. A significant increase 
in the wound-healing activity was observed in the animals treated with 
the extract, compared with those received the control treatments. This 
investigate showed that healing percentage in A. eburnea extract was 
85.91%, while in silver groups was 81.50% and in control groups was 
68.78% (p<0.05). Therefore, healing percent progress on A. eburnean 
extract was more than silver sulfadiazine and control groups in all days, 
and healing percent progress on control group was loss than another 
group. Healing time in treatment with A. eburnean was significantly 
shorter than silver sulfadiazine.
According to the homogeneity of variances tests at day 3, 6, 12, and 15 
confidence level are 0.338, 0.502, 0.115, and 0.074 (>0.05), respectively, 
and conclude that the variance is constant.
The one-way ANOVA is used to test for differences among control, 
extract and silver groups at day 3, 6, 12, and 15. Since the confidence 
interval on the 3rd day and 6th is 0.89 and 0.849 respectively (p>0.05) 
can be said healing rate percentage are same for all three groups in 
these 2 days. Differences of wound healing rate percentage in extract 
and silver groups are not significant at 12th day, but according to 
descriptive statistics, it can be concluded wound healing rate in control 
group is less than them. As a result, statistically, the percentage of 
wound contraction showed that there is high significant difference 
between the different groups in the 15th day. Moreover, Tukey test 
demonstrates the difference of wound healing between silver and 
extract groups was not significant, but their percentage of healing rate 
was better than the control group. Investigate of wound healing rate 
in all days for three groups indicate that differences of wound healing 
surface area for all three groups were not significant, although the best 
results of wound healing in all days were obtained in extract group. The 
difference between silver and extract group was not significant, but in 
extract group, healing rate was better 7th, 8th and near the end of the 
study. However, healing rate in control group was similar to that of 
extract and silver group in 1st, 2nd, 6th and 9th days, the speed of healing 
was lower in the other [28].
Wound healing process consists of inflammation, re-epithelialization, 
granulation and neovascularization, which result in wound contraction. 
In histopathological study regarding the inflammation, in 6th day 
re-epithelialization was not significant in control group, and a little 
granulation tissue formation was observed. Furthermore, necrotic tissue 
with severe edema and infiltration of inflammatory cells with dominance 
neutrophil is visible. In the extract group, there was less inflammatory 
reaction of neutrophils and edema. Inflammatory infiltration was 
observed. Furthermore, in addition to neutrophils, a large number 
of macrophages infiltrated. In wound margins, epithelial hyperplasia 
occurred. Granulation tissue formation was with angiogenesis. The 
healing process in silver group was similar to the extract group.
In the 12th day of experiment, incomplete monolayer of epidermal cells 
(in most of cases, about 30% of the damaged area was still without 
re-epithelialization) with evidence of crusting in control group was also 
observed. Furthermore, granulation tissue with good thickness in the 
wound edges observed. In some cases, immature granulation tissue with 
high levels of inflammatory cells in the dermis was seen. In extract group, 
epidermis exhibited well-structured layers without any crusting. Extract 
was effective on burn wound with increase in thickness of granulation 
tissue and re-epithelialization. It also decreased the inflammatory 
reactions. Although up to 80% burns in silver were covered by the new 
re-epithelialization, thickness of re-epithelialization was not significant. 
Granulation tissue with minimum inflammatory cells in the dermis was 
made. Re-epithelialization was prominent in extract group.
A. eburnea has been used as a medicinal herb since ancient times in 
Iran. The present study has shown that the extract from the A. eburnean 
as an available and inexpensive herb possesses wound healing activity, 
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and thus provided the evidence for its traditional use value and it is 
suitable substitute in healing of burn wounds.
A. eburnea extract to restore burned tissue and facilitate skin 
regeneration. Moreover, A. eburnea inhibit the growth of 
microorganisms, therefore, this finding support the use of A. eburnea in 
the management of burn wound infection. In concluded, A. eburnea can 
be an effective treatment for third-degree burns. Advanced clinical and 
pharmaceutical studies are recommended to the production of novel 
natural drugs for burn wound treatment.
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